Debate › Detransition · Last reviewed 2026-05-16

Detransition research

Summary

Detransition — discontinuing medical transition and returning to identification with the birth sex — has been documented in a growing number of publications. Prevalence estimates range from under 1% in clinical cohort studies to well above 10% in self-report surveys; methodological differences in definition and sample are substantial. See also /studies/de-vries-2014/ and /studies/sample-size-and-attrition/.

1. Key publications

  • Littman L. Individuals treated for gender dysphoria with medical and/or surgical transition who subsequently detransitioned. Arch Sex Behav. 2021;50:3353–69.
  • Vandenbussche E. Detransition-related needs and support. J Homosex. 2022;69(9):1602–20.
  • Boyd I, Hackett T, Bewley S. Care of transgender patients: a general practice quality improvement approach. Healthcare (Basel). 2022;10(1):121.
  • Hall R, Mitchell L, Sachdeva J. Access to care and frequency of detransition among a cohort of UK gender service users. BJPsych Open. 2021;7(6):e184.

2. Prevalence estimates

StudynDetransition rate
van der Loos 2022 (Amsterdam UMC) — see follow-up overview7202.0%
Hall 2021 (UK NHS) — see UK1756.9%
Littman 2021 (online survey)100self-selected — n/a
Vandenbussche 2022 (online survey)237self-selected — n/a

3. Methodological notes

  • Definitional question: detransition ≠ identity revision; some detransitioners continue to identify as trans.
  • Clinical cohorts primarily register patients who remain in contact with the clinic; attrition may lead to underestimation — see /studies/sample-size-and-attrition/.
  • Online surveys have self-selection bias; prevalence estimates not generalisable.

See also

Detransition across the network

Other sites in this network also cover this topic: